ArticleJournal of personalized medicine2022

Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer.

Xing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.